Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Academic Drug Discovery 2015

Sir Tom Blundell's Biography

Sir Tom Blundell, Professor, University of Cambridge

Tom Blundell is Sir William Dunn Professor of Biochemistry and Head of Biological Sciences in the University of Cambridge. He researches on structural biology of cell regulation, structural bioinformatics and applications to drug discovery and medicine. He is Member of Academia Europaea, Fellow of the Royal Society and Fellow of Academy of Medical Sciences. He has Honorary Doctorates from fifteen universities. He was a member of ACOST, the advisory group to the PM in the 1980s, founding CEO BBSRC in 1990s and Chairman of the Royal Commission on Environmental Pollution 1998 to 2005. He co-founded Astex Therapeutics, he was Non-Executive Director of Celltech from 1996 to 2005 and has been science advisor to Pfizer, UCB and SKB.

Sir Tom Blundell Image

Structural Biology and Drug Discovery: Targeting Protein-Protein Interfaces

Tuesday, 19 May 2015 at 09:45

Add to Calendar ▼2015-05-19 09:45:002015-05-19 10:45:00Europe/LondonStructural Biology and Drug Discovery: Targeting Protein-Protein InterfacesAcademic Drug Discovery 2015 in

Targeting protein-protein interfaces of multiprotein assemblies offers opportunities for improving specificity and selectivity in drug discovery.  I will describe computational analyses of protein interface landscapes for multiprotein assemblies and exemplify use of fragment-based approaches for two very different PPI targets.

Add to Calendar ▼2015-05-19 00:00:002015-05-20 00:00:00Europe/LondonAcademic Drug Discovery 2015Academic Drug Discovery 2015 in